EUVIMEDEUVIMED entdecken
Fallbericht

Management of Neuroendocrine Ductal Carcinoma In Situ of the Breast

Brenda L Ma, Clayton O Rooks, Wade O Christopher, Scott M Berry

The American Surgeon™ · 2023

DOI: 10.1177/00031348231161080 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The American Surgeon™, 2023. Verfasst von Brenda L Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Mississippi Medical Center, Jackson, MS, USA. Hauptthemen laut MEDLINE: Carcinoma, Intraductal, Noninfiltrating, Breast Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine tumors are defined as tumors that express neuroendocrine markers, specifically synaptophysin and/or chromogranin in at least 50% of tumor cells. To date, neuroendocrine cancers of the breast are extremely rare with reports that they account for less than 1% of all neuroendocrine tumors and less than .1% of all breast cancers. Limited literature exists to guide treatment decisions tailored to neuroendocrine tumors of the breast, despite the possibility that they may be associated with an overall worse prognosis. We present a rare case of neuroendocrine ductal carcinoma in situ (NE-DCIS) which was discovered upon workup for bloody nipple discharge. In this case, NE-DCIS was managed with the standard recommended treatment regimen for ductal carcinoma in situ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Intraductal, NoninfiltratingBreast NeoplasmsCarcinoma, NeuroendocrineNeuroendocrine TumorsHumansFemaleBreast

Stichwörter der Autor:innen

breastductal carcinoma in situneuroendocrine

Autor:innen und Institutionen

  • Department of Surgery, University of Mississippi Medical Center, Jackson, MS, USA.
  • Department of Surgery, Division of Surgical Oncology, University of Mississippi Medical Center, Jackson, MS, USA.
  • Department of Surgery, Division of Breast Surgery, University of Mississippi Medical Center, Jackson, MS, USA.

Zitieren

APA

Ma, B. L., Rooks, C. O., Christopher, W. O., & Berry, S. M. (2023). Management of Neuroendocrine Ductal Carcinoma In Situ of the Breast. The American Surgeon™. https://doi.org/10.1177/00031348231161080

Vancouver

Ma BL, Rooks CO, Christopher WO, Berry SM. Management of Neuroendocrine Ductal Carcinoma In Situ of the Breast. The American Surgeon™. 2023. doi:10.1177/00031348231161080

BibTeX
@article{Ma2023,
  author = {Ma, Brenda L and Rooks, Clayton O and Christopher, Wade O and Berry, Scott M},
  title = {Management of Neuroendocrine Ductal Carcinoma In Situ of the Breast},
  journal = {The American Surgeon™},
  year = {2023},
  doi = {10.1177/00031348231161080}
}
Kostenlos starten →